Sweden
· Delayed Price · Currency is SEK SenzaGen AB Statistics
Total Valuation
SenzaGen AB has a market cap or net worth of SEK 141.32 million. The enterprise value is 108.08 million.
| Market Cap | 141.32M |
| Enterprise Value | 108.08M |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SenzaGen AB has 29.50 million shares outstanding. The number of shares has increased by 18.31% in one year.
| Current Share Class | 29.50M |
| Shares Outstanding | 29.50M |
| Shares Change (YoY) | +18.31% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.79% |
| Owned by Institutions (%) | 26.81% |
| Float | 21.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.48 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 3.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.72 |
| EV / Sales | 1.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.43 |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.97 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -132.86 |
Financial Efficiency
Return on equity (ROE) is -25.79% and return on invested capital (ROIC) is -9.50%.
| Return on Equity (ROE) | -25.79% |
| Return on Assets (ROA) | -7.41% |
| Return on Invested Capital (ROIC) | -9.50% |
| Return on Capital Employed (ROCE) | -13.89% |
| Revenue Per Employee | 1.68M |
| Profits Per Employee | -555,559 |
| Employee Count | 34 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.68% in the last 52 weeks. The beta is 0.30, so SenzaGen AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -49.68% |
| 50-Day Moving Average | 5.11 |
| 200-Day Moving Average | 6.62 |
| Relative Strength Index (RSI) | 41.01 |
| Average Volume (20 Days) | 23,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SenzaGen AB had revenue of SEK 57.02 million and -18.89 million in losses. Loss per share was -0.66.
| Revenue | 57.02M |
| Gross Profit | 38.20M |
| Operating Income | -11.43M |
| Pretax Income | -19.39M |
| Net Income | -18.89M |
| EBITDA | -3.44M |
| EBIT | -11.43M |
| Loss Per Share | -0.66 |
Balance Sheet
The company has 34.69 million in cash and 1.45 million in debt, giving a net cash position of 33.24 million or 1.13 per share.
| Cash & Cash Equivalents | 34.69M |
| Total Debt | 1.45M |
| Net Cash | 33.24M |
| Net Cash Per Share | 1.13 |
| Equity (Book Value) | 80.82M |
| Book Value Per Share | 2.74 |
| Working Capital | 36.38M |
Cash Flow
In the last 12 months, operating cash flow was -6.61 million and capital expenditures -879,000, giving a free cash flow of -7.49 million.
| Operating Cash Flow | -6.61M |
| Capital Expenditures | -879,000 |
| Free Cash Flow | -7.49M |
| FCF Per Share | -0.25 |
Margins
Gross margin is 67.01%, with operating and profit margins of -20.04% and -33.13%.
| Gross Margin | 67.01% |
| Operating Margin | -20.04% |
| Pretax Margin | -34.01% |
| Profit Margin | -33.13% |
| EBITDA Margin | -6.04% |
| EBIT Margin | -20.04% |
| FCF Margin | n/a |
Dividends & Yields
SenzaGen AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.31% |
| Shareholder Yield | -18.31% |
| Earnings Yield | -13.37% |
| FCF Yield | -5.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |